Targeting of tumor-associated angiogenic tip and stalk cells with immunoliposomes (ILs) directed against VEGFR-2 and VEGFR-3

被引：0
|
作者：
Wicki, A. [1 ,2 ]
Rochlitz, C. [1 ]
Orleth, A. [2 ]
Ritschard, R. [2 ]
Herrmann, R. [1 ]
Alitalo, K. [3 ]
Christofori, G. [4 ]
Mamot, C. [5 ]
机构：
[1] Univ Spital Basel, Basel, Switzerland
[2] Univ Basel, Labor Med Onkol, Basel, Switzerland
[3] Univ Helsinki, Helsinki, Finland
[4] Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland
[5] Kantonsspital Aarau, Aarau, Switzerland
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 31 条
  • [1] Selective targeting of tumor-associated angiogenic tip and stalk cells with immunoliposomes (ILs) directed against VEGFR-2 and VEGFR-3 expressing cells
    Wicki, Andreas
    Rochlitz, Christoph
    Orleth, Annette
    Ritschard, Reto
    Alitalo, Kari
    Herrmann, Richard
    Christofori, Gerhard
    Mamot, Christoph
    [J]. CANCER RESEARCH, 2011, 71
  • [2] Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
    Lothar C. Dieterich
    Luca Ducoli
    Jay W. Shin
    Michael Detmar
    [J]. Scientific Data, 4
  • [3] Analysis: Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
    Dieterich, Lothar C.
    Ducoli, Luca
    Shin, Jay W.
    Detmar, Michael
    [J]. SCIENTIFIC DATA, 2017, 4
  • [4] Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth
    Wicki, Andreas
    Rochlitz, Christoph
    Orleth, Annette
    Ritschard, Reto
    Albrecht, Imke
    Herrmann, Richard
    Christofori, Gerhard
    Mamot, Christoph
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (02) : 454 - 464
  • [5] Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
    Melissa García-Caballero
    Jenny Paupert
    Silvia Blacher
    Maureen Van de Velde
    Ana Rodríguez Quesada
    Miguel Angel Medina
    Agnès Noël
    [J]. Journal of Hematology & Oncology, 10
  • [6] Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
    Garcia-Caballero, Melissa
    Paupert, Jenny
    Blacher, Silvia
    Van de Velde, Maureen
    Rodriguez Quesada, Ana
    Angel Medina, Miguel
    Noel, Agnes
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [7] Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3
    Tanno, S
    Ohsaki, Y
    Nakanishi, K
    Toyoshima, E
    Kikuchi, K
    [J]. LUNG CANCER, 2004, 46 (01) : 11 - 19
  • [8] Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
    Padera, Timothy P.
    Kuo, Angera H.
    Hoshida, Tohru
    Liao, Shan
    Lobo, Jennifer
    Kozak, Kevin R.
    Fukumura, Dai
    Jain, Rakesh K.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) : 2272 - 2279
  • [9] 2-Cyanopyridines as novel VEGFR-2 / VEGFR-3 inhibitors. Part 2. Inhibition of tumor growth and metastasis by a cyanopyridine
    Adnane, Lila
    Scott, William J.
    Adams, Paul
    Li, Volkhart
    Wilhelm, Scott M.
    Hofilena, Gloria
    Ichetovkin, Marina
    Lantz, Lori
    Lyga, Andrew
    Wilkie, Dean
    Noell, Stephen
    Cao, Yichen
    Lee, Wendy
    Raudenbush, Brian
    Carter, Christopher
    Trail, Pamela A.
    Bull, Cathy
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [10] Bone marrow-derived EP3-expressing stromal cells enhanced tumor-associated angiogenesis and tumor growth with increased recruitment of VEGFR-1/VEGFR-2 positive cells
    Ogawa, Yasufumi
    Oikawa, Atsuhiko
    Suzuki, Tatsunori
    Hosono, Kanako
    Amano, Hideki
    Watanabe, Masahiko
    Narumiya, Syuh
    Majima, Masataka
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 267P - 267P
1234